If you have been reading about bioavailability and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
==== Elimination ==== Minoxidil is excreted almost exclusively (>97%) in urine. About 10 to 15% is excreted in urine unchanged. The elimination half-life of oral minoxidil is about 3 to 4 hours. Conversely, the half-life of topical minoxidil is 22 hours on average. Oral minoxidil is excreted within 12 to 20 hours in urine. Despite this however, the hypotensive effect of oral minoxidil lasts approximately 72 hours following a single dose. With discontinuation of topical minoxidil, about 95% of systemically absorbed minoxidil is excreted within 4 days. The renal clearance of oral minoxidil is 352 mL/minute.
Deep sea communities around Japan are mainly researched by Japan Agency for Marine-Earth Science and Technology (JAMSTEC). DSV Shinkai 6500, Kaikō, and other groups have discovered many sites. Methane seep communities in Japan are distributed along plate convergence areas because of the accompanying tectonic activity. Many seeps have been found in the Japan Trench, Nankai Trough, Ryukyu Trench, Sagami Bay, Suruga Bay, and the Sea of Japan. Members of cold seep communities are similar to other regions in terms of family or genus, such as Polycheata, Lamellibrachia, Bivalavia, Solemyidae, Bathymodiolus in Mytilidae, Thyasiridae, Calyptogena in Vesicomyidae, and so forth. Many of the species in Japan's cold seeps are endemic. In Kagoshima Bay, there are methane gas seepages called "tagiri" (boiling). Lamellibrachia satsuma live around there. The depth of this site is only 80 m, which is the shallowest point where Siboglinidae are known to live. L. satsuma may be kept in an aquarium for a long period at 1 atm. Two aquariums in Japan are keeping and displaying L. satsuma. An observation method to introduce it into a transparent vinyl tube is being developed.
Freeze-drying is another promising alternative for storing semen for its accessibility with regular refrigeration. This method has been successfully replicated in animal species. However, DNA can be damaged in this process, therefore further research is warranted to determine factors that can affect the efficacy of this method.
===== MeSH D08.811.399.325 – cis-trans-isomerases (EC 5.2) ===== MeSH D08.811.399.325.500 – peptidylprolyl isomerase MeSH D08.811.399.325.500.400 – immunophilins MeSH D08.811.399.325.500.400.300 – cyclophilins MeSH D08.811.399.325.500.400.300.500 – cyclophilin A MeSH D08.811.399.325.500.400.700 – tacrolimus binding proteins MeSH D08.811.399.325.500.400.700.500 – tacrolimus binding protein 1a
Sources: en.wikipedia.org
=== Appearance === Color: LEDs can emit light of an intended color without using any color filters as traditional lighting methods need. This is more efficient and can lower initial costs. Cool light: In contrast to most light sources, LEDs radiate very little heat in the form of IR that can cause damage to sensitive objects or fabrics. Wasted energy is dispersed as heat through the base of the LED. Color rendition: Most cool-white LEDs have spectra that differ significantly from a black body radiator like the sun or an incandescent light. The spike at 460 nm and dip at 500 nm can make the color of objects appear differently under cool-white LED illumination than sunlight or incandescent sources, due to metamerism, red surfaces being rendered particularly poorly by typical phosphor-based cool-white LEDs. The same is true with green surfaces. The quality of color rendition of an LED is measured by the Color Rendering Index (CRI). Dimming: LEDs can be dimmed either by pulse-width modulation or lowering the forward current. This pulse-width modulation is why LED lights, particularly headlights on cars, when viewed on camera or by some people, seem to flash or flicker. This is a type of stroboscopic effect.
== D == D-arabinitol 2-dehydrogenase - D-arabinose 1-dehydrogenase (NAD(P)+) - database search - degeneracy (biology) - deletion - denaturation - denaturing gel - deoxyribonuclease (DNase) - deoxyribonucleic acid - deoxyribonucleotide - deoxyuridine phosphorylase - diabetes mellitus - dideoxy sequencing - dideoxyribonucleotide - diethyl 2-methyl-3-oxosuccinate reductase - dihydrochelirubine 12-monooxygenase - dimethyl sulfide:cytochrome c2 reductase - diploid - direct repeat - directionality - DLG2-AS1 - DNA ligase -DNA Bank - DNA polymerase - DNA replication - DNA sequencing - DNase - dominant - dot blot - double helix - downstream (DNA) - downstream (transduction) - drimenol cyclase- ds - duplex -
When the U.S. government created the United States Agency for International Development (USAID) in November 1961, it built on a legacy of previous development-assistance agencies and their people, budgets, and operating procedures. USAID's predecessor agency was already substantial, with 6,400 U.S. staff in developing-country field missions in 1961. Except for the peak years of the Vietnam War, 1965–70, that was more U.S. field staff than USAID would have in the future, and triple the number USAID has had in field missions in the years since 2000. Although the size of the development-assistance effort was not new, the 1961 decision to reorganize the government's main development-assistance agency was a landmark in terms of institutional evolution, representing the culmination of twenty years' experience with different organizational forms and procedures, in changing foreign-policy environments. The new structure created in 1961 "proved to be sturdy and durable". In particular, the U.S. government has maintained since then "the unique American pattern of placing strong resident aid missions in countries that [the U.S. was] helping." The story of how the base for USAID's structure was built is described below, along with an account of changes that have been made since 1961.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.